Newsmeme!
Discover News you didn't know existed
Oocyte
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Schering-Plough announces phase II and III data for corifollitropin alfa
Published July 2, 2009, 9:48 pm, PharmaBiz
Schering-Plough Corp., announced results from the phase III Engage clinical trial demonstrating that a single injection of corifollitropin alfa, first in the class of sustained follicle stimulants, achieved similar efficacy to recombinant follicle stimulating hormone (rFSH) given once daily for seven days.
My Pharmiweb.com
Published July 2, 2009, 3:49 am, PharmiWeb
AMSTERDAM, THE NETHERLANDS , July 1, 2009 -- Schering-Plough Corp ., (NYSE: SGP) today announced results from the Phase III ENGAGE clinical trial demonstrating that a single injection of corifollitropin alfa, first in the class of sustained follicle stimulants, achieved similar efficacy to recombinant follicle stimulating hormone (rFSH) given once daily for seven days.
My Pharmiweb.com
Published July 2, 2009, 2:34 am, PharmiWeb
AMSTERDAM, THE NETHERLANDS, July 1, 2009 Schering-Plough Corp., (NYSE: SGP) today announced results from the Phase III ENGAGE clinical trial demonstrating that a single injection of corifollitropin alfa, first in the class of sustained follicle stimulants, achieved similar efficacy to recombinant follicle stimulating hormone (rFSH) given once daily for seven days.
Association Between Reduced Ovarian Reserve And Increased Risk Of Trisomic Pregnancy
Published July 1, 2009, 8:08 am, Medical News Today
Women who have a diminished number of eggs in their ovaries, either because they are older or for some other reason such as ovarian surgery, may be more at risk of a trisomic pregnancy than women with an ovarian reserve within the normal, fertile range. Trisomic pregnancies occur when the embryo has three copies of a chromosome rather than the normal two.
Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
Published July 1, 2009, 6:00 am, PR Newswire via Yahoo! Finance
dose of investigational sustained follicle stimulant achieves similar efficacy to daily injections of follitropin beta given over a one week period in Phase III Study
Reduced ovarian reserve is associated with an increased risk of trisomic pregnancy
Published June 30, 2009, 1:42 pm, News-Medical-Net
Women who have a diminished number of eggs in their ovaries, either because they are older or for some other reason such as ovarian surgery, may be more at risk of a trisomic pregnancy than women with an ovarian reserve within the normal, fertile range.
Who Goes Abroad For Fertility Treatment And Why?
Published June 30, 2009, 8:11 am, Medical News Today
A substantial number of European patients travel to other countries for fertility treatment, both because they think that they will receive better quality care abroad and in order to undergo procedures that are banned in their home country says a study of the subject launched at the 25th annual conference of the European Society of Human Reproduction and Embryology. Study co-ordinator Dr.
Reduced ovarian reserve associated with increased risk of trisomic pregnancy
Published June 30, 2009, 6:24 am, EurekAlert!
( European Society for Human Reproduction and Embryology ) Women who have a diminished number of eggs in their ovaries, either because they are older or for some other reason such as ovarian surgery, may be more at risk of a trisomic pregnancy than women with an ovarian reserve within the normal, fertile range, Dutch researchers have found.
New Ovarian Transplantation Technique Gives Greatly Improved Results In This Delicate Operation
Published June 30, 2009, 6:07 am, Medical News Today
Ultra-fast freezing of ovarian tissue from women who have lost their fertility as a result of cancer treatment can lead to it being used in transplants with the same success rate as fresh tissue, a researcher told the 25th annual conference of the European Society of Human Reproduction and Embryology 29 June. Dr. Sherman Silber, Director of the St. Louis Infertility Centre, St.
First ever study of European patients shows large numbers crossing borders for reproductive therapies
Published June 29, 2009, 4:27 pm, News-Medical-Net
A substantial number of European patients travel to other countries for fertility treatment, both because they think that they will receive better quality care abroad and in order to undergo procedures that are banned in their home country says a study of the subject launched at the 25th annual conference of the European Society of Human Reproduction and Embryology.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |